| Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype D Lacedonia, GP Palladino, MP Foschino-Barbaro, G Scioscia, ... International journal of chronic obstructive pulmonary disease, 1811-1817, 2017 | 82 | 2017 |
| Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations G Scioscia, I Blanco, E Arismendi, F Burgos, C Gistau, MPF Barbaro, ... Thorax 72 (2), 117-121, 2017 | 73 | 2017 |
| Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab GE Carpagnano, G Scioscia, D Lacedonia, G Curradi, ... Journal of asthma and allergy, 83-90, 2019 | 62 | 2019 |
| Benralizumab effectiveness in severe eosinophilic asthma with and without chronic rhinosinusitis with nasal polyps: a real-world multicenter study S Nolasco, C Crimi, C Pelaia, A Benfante, MF Caiaffa, C Calabrese, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (12), 4371 …, 2021 | 52 | 2021 |
| Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: real-life evaluation correlated with allergic and non-allergic phenotype expression C Pelaia, C Crimi, A Benfante, MF Caiaffa, C Calabrese, GE Carpagnano, ... Journal of Asthma and Allergy, 163-173, 2021 | 48 | 2021 |
| Switching from omalizumab to mepolizumab: real-life experience from Southern Italy GE Carpagnano, C Pelaia, M D’Amato, N Crimi, N Scichilone, G Scioscia, ... Therapeutic advances in respiratory disease 14, 1753466620929231, 2020 | 45 | 2020 |
| Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients D Lacedonia, G Scioscia, C Santomasi, P Fuso, GE Carpagnano, ... Scientific Reports 11 (1), 19251, 2021 | 44 | 2021 |
| <? covid19?> Tocilizumab and liver injury in patients with COVID-19 G Serviddio, R Villani, G Stallone, G Scioscia, MP Foschino-Barbaro, ... Therapeutic Advances in Gastroenterology 13, 1756284820959183, 2020 | 43 | 2020 |
| Real-world experience with dupilumab in severe asthma: one-year data from an Italian named patient program R Campisi, C Crimi, S Nolasco, B Beghè, L Antonicelli, G Guarnieri, ... Journal of asthma and allergy, 575-583, 2021 | 40 | 2021 |
| Real time PCR and culture-based virus isolation test in clinically recovered patients: is the subject still infectious for SARS-CoV2? V Manzulli, G Scioscia, G Giganti, MR Capobianchi, D Lacedonia, L Pace, ... Journal of clinical medicine 10 (2), 309, 2021 | 33 | 2021 |
| Severe Asthma Network Italy definition of clinical remission in severe asthma: a Delphi consensus GW Canonica, F Blasi, GE Carpagnano, G Guida, E Heffler, P Paggiaro, ... The Journal of Allergy and Clinical Immunology: In Practice, 2023 | 32 | 2023 |
| Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases GE Carpagnano, D Lacedonia, M Carone, P Soccio, G Cotugno, ... Journal of Breath Research 10 (2), 026005, 2016 | 32 | 2016 |
| Looking for airways periostin in severe asthma: could it be useful for clustering type 2 endotype? GE Carpagnano, G Scioscia, D Lacedonia, P Soccio, G Lepore, M Saetta, ... Chest 154 (5), 1083-1090, 2018 | 26 | 2018 |
| Severe asthma: One disease and multiple definitions D Bagnasco, P Paggiaro, M Latorre, C Folli, E Testino, A Bassi, ... World Allergy Organization Journal 14 (11), 100606, 2021 | 24 | 2021 |
| Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis D Di Bona, C Crimi, AM D’Uggento, A Benfante, MF Caiaffa, C Calabrese, ... Clinical & Experimental Allergy 52 (2), 312-323, 2022 | 23 | 2022 |
| Association between physical activity and risk of hospitalisation in bronchiectasis V Alcaraz-Serrano, E Gimeno-Santos, G Scioscia, A Gabarrús, A Navarro, ... European Respiratory Journal 55 (6), 2020 | 23 | 2020 |
| MicroRNA expression profile during different conditions of hypoxia D Lacedonia, G Scioscia, GP Palladino, C Gallo, GE Carpagnano, ... Oncotarget 9 (80), 35114, 2018 | 22 | 2018 |
| Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps C Pelaia, A Benfante, MT Busceti, MF Caiaffa, R Campisi, ... Frontiers in Immunology 14, 1121237, 2023 | 21 | 2023 |
| Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis S Dragonieri, G Scioscia, VN Quaranta, P Carratu, MP Venuti, M Falcone, ... Journal of Breath Research 14 (4), 047101, 2020 | 21 | 2020 |
| Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis D Lacedonia, G Scioscia, P Soccio, M Conese, L Catucci, GP Palladino, ... BMC pulmonary medicine 21 (1), 188, 2021 | 20 | 2021 |
